ENTPD1 and inflammatory bowel disease: A decrease in CD39 expressing cells was recently reported in a cohort of pediatric IBD patients along with other immunological alterations like infiltration of phosphodiesterase 4B and TNF-α expressing macrophages, impaired cyclic-AMP response signaling, and platelet aggregation (Huang et al., 2019).